학술논문
N°356 - Muscle velocity recovery cycles as pharmacodynamic biomarker in a first-in-human trial of a first-in-class chloride channel 1 inhibitor: A randomized, double-blind, placebo-controlled, cross-over study in healthy subjects and patients with myasthenia grav
Document Type
Abstract
Author
Source
In Clinical Neurophysiology June 2023 150:e183-e184
Subject
Language
ISSN
1388-2457